LION BIOTECHNOLOGIES, INC.

Profile

Company Names

LION BIOTECHNOLOGIES, INC.
GENESIS BIOPHARMA, INC

Addresses

112 WEST 34TH STREET, 17TH FLOOR, NEW YORK, NY 10120

21900 BURBANK BLVD., THIRD FLOOR, WOODLAND HILLS, CA 91367

10960 WILSHIRE BOULEVARD, SUITE 1050, LOS ANGELES, CA 90024

11500 OLYMPIC BOULEVARD, SUITE 400, LOS ANGELES, CA 90064

11500 OLYMPIC BOULEVARD, LOS ANGELES, CA 90064

1601 N. SEPULVEDA BLVD., #632, MANHATTAN BEACH, CA 90266

Phone Numbers

212-946-4826
818-992-3126
866-963-2220

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

NEVADA

Total Amount Raised:

$131,530,600.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2016-06-02 
$100,000,000.00 
$100,000,000.00 
$0.00 
Equity 
7
2013-11-05 
$23,290,600.00 
$23,290,600.00 
$0.00 
Equity 
6
2013-05-22 
$1,350,000.00 
$1,350,000.00 
$0.00 
Equity 
5
2011-07-27 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
4
2011-04-17 
$500,000.00 
$1,000,000.00 
$500,000.00 
Equity 
3
2010-12-28 
$640,000.00 
$640,000.00 
$0.00 
Equity 
2
2010-10-22 
$250,000.00 
$250,000.00 
$0.00 
Equity 
1
2010-09-17 
$500,000.00 
$500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
IBRAHIM 
 
ABOTALEB 
PROMOTER
GENESIS BIOPHARMA, INC
MARK 
J. 
AHN 
DIRECTOR
GENESIS BIOPHARMA, INC   |  PLASMATECH BIOPHARMACEUTICALS INC
DR. WILLIAM 
 
ANDREWS 
DIRECTOR
GENESIS BIOPHARMA, INC
ROBERT 
T. 
BROOKE 
EXECUTIVE OFFICER, DIRECTOR
GENESIS BIOPHARMA, INC
ANTHONY 
 
CATALDO 
DIRECTOR, EXECUTIVE OFFICER
GENESIS BIOPHARMA, INC   |  OXIS INTERNATIONAL INC   |  GT BIOPHARMA, INC.
DR. L. 
STEPHEN 
COLES 
DIRECTOR
GENESIS BIOPHARMA, INC
MARIA 
 
FARDIS 
EXECUTIVE OFFICER, DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  QUANTA THERAPEUTICS, INC.   |  AIRNEXIS THERAPEUTICS, INC.
STEVEN 
A. 
FISCHKOFF 
EXECUTIVE OFFICER
LION BIOTECHNOLOGIES, INC.
MICHAEL 
 
HANDELMAN 
EXECUTIVE OFFICER, DIRECTOR
GENESIS BIOPHARMA, INC   |  LION BIOTECHNOLOGIES, INC.   |  GENIUS BRANDS INTERNATIONAL, INC.
MOLLY 
C. 
HENDERSON 
EXECUTIVE OFFICER
LION BIOTECHNOLOGIES, INC.
SANFORD 
 
HILLSBERG 
DIRECTOR
LION BIOTECHNOLOGIES, INC.
SANFORD 
J, 
HILLSBERG 
DIRECTOR
LION BIOTECHNOLOGIES, INC.
PAUL 
 
KESSLER 
DIRECTOR
GENESIS BIOPHARMA, INC   |  WIZARD ENTERTAINMENT, INC.
GERALD 
 
LEWIS 
PROMOTER
GENESIS BIOPHARMA, INC
MICHAEL 
T. 
LOTZE 
EXECUTIVE OFFICER
LION BIOTECHNOLOGIES, INC.
RYAN 
 
MAYNARD 
DIRECTOR
LION BIOTECHNOLOGIES, INC.
RICHARD 
 
MCKILLIGAN 
EXECUTIVE OFFICER, DIRECTOR
DERYCZ SCIENTIFIC INC   |  GENESIS BIOPHARMA, INC
MERRILL 
 
MCPEAK 
EXECUTIVE OFFICER, DIRECTOR
DERYCZ SCIENTIFIC INC   |  GENESIS BIOPHARMA, INC   |  LION BIOTECHNOLOGIES, INC.   |  RESEARCH SOLUTIONS, INC.   |  LILIS ENERGY, INC.
MERRILL 
A. 
MCPEAK 
DIRECTOR
BLACKLIGHT POWER INC   |  GENESIS BIOPHARMA, INC
WAYNE 
 
ROTHBAUM 
DIRECTOR
LION BIOTECHNOLOGIES, INC.
MARTIN 
 
SCHROEDER 
DIRECTOR
GENESIS BIOPHARMA, INC
MANISH 
 
SINGH 
EXECUTIVE OFFICER, DIRECTOR
IMMUNOCELLULAR THERAPEUTICS, LTD.   |  LION BIOTECHNOLOGIES, INC.   |  TENETX INC.
JAY 
 
VENKATESAN 
DIRECTOR
LION BIOTECHNOLOGIES, INC.   |  AURASENSE THERAPEUTICS, LLC   |  ONCOTHYREON INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  TRANSPLANT GENOMICS INC.   |  ANGION BIOMEDICA CORP.   |  TIVORSAN PHARMACEUTICALS, INC.   |  ALPINE IMMUNE SCIENCES, INC.   |  ELICIO THERAPEUTICS, INC.
DAVID 
 
VOYTICKY 
DIRECTOR
BEST ENERGY SERVICES, INC.   |  GENESIS BIOPHARMA, INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-06-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2016-06-02 
2013-11-15
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
DECLINE TO DISCLOSE 
Equity 
2013-11-05 
2013-06-06
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
DECLINE TO DISCLOSE 
Equity 
2013-05-22 
2011-08-09
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
NO REVENUES 
Debt 
2011-07-27 
2011-05-03
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
NO REVENUES 
Equity 
2011-04-17 
2011-01-21
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
NO REVENUES 
Equity 
2010-12-28 
2010-11-08
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
NO REVENUES 
Equity 
2010-10-22 
2010-10-01
D
Link
BIOTECHNOLOGY 
ARRANGEMENT OF TRANSPORTATION OF FREIGHT + CARGO [4731] 
NO REVENUES 
Equity 
2010-09-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
2347
NONE
NONE
PIPER JAFFRAY + CO.
665
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407
NONE
NONE
SCARSDALE EQUITIES LLC
134602
NONE
NONE
AMERICAN PORTFOLIO FINANCIAL SERVICES, INC.
18487
NONE
NONE
AGINCOURT, LTD.
36661
NONE
NONE
CANACCORD GENUITY, INC.
1020
NONE
NONE
COWEN AND COMPANY LLC
7616